QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study 期刊论文 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wei, Jingwen;  Xiang, Jing;  Hao, Yue;  Si, Jinfei;  Wang, Wenxian 收藏  |  浏览/下载：16/0  |  提交时间：2022/12/22 Anemia  Epidermal growth factor receptor  Epidermal growth factor receptor tyrosine kinase inhibitors  Non-small cell lung cancer   Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan 收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23 Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors   The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients 期刊论文 INTERNATIONAL JOURNAL OF CANCER, 2021 作者:  Cai, Lei;  Chen, Yong;  Tong, Xiaoling;  Wu, Xue;  Bao, Hua 收藏  |  浏览/下载：66/0  |  提交时间：2021/06/15 EGFR  ERBB2  gene fusions  tyrosine kinase inhibitors  young lung cancer patients   Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer 期刊论文 CANCER MANAGEMENT AND RESEARCH, 2021, 卷号: 13 作者:  Xu, Yi-Bing;  Zhang, Yiping;  Song, Zhengbo;  Wang, Wenxian;  Shao, Lan 收藏  |  浏览/下载：40/0  |  提交时间：2021/09/06 cystic brain metastases  tyrosine kinase inhibitors  chemotherapy  radiation therapy  lung cancer   Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun 收藏  |  浏览/下载：21/0  |  提交时间：2020/10/26 tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)   Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice 期刊论文 ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38 - 收藏  |  浏览/下载：5/0  |  提交时间：2020/10/26 BRAIN METASTASES  CEREBROSPINAL-FLUID  GEFITINIB  INHIBITORS  CARCINOMA  RADIATION  ERLOTINIB  afatinib  tyrosine kinase inhibitor  non-small cell lung cancer  brain metastasis  pharmacokinetic/pharmacodynamics  pEGFR   Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy 期刊论文 CHINESE MEDICAL JOURNAL, 2014, 卷号: 127 - 收藏  |  浏览/下载：1/0  |  提交时间：2020/10/26 PREVIOUSLY TREATED PATIENTS  TYROSINE KINASE INHIBITORS  FACTOR RECEPTOR MUTATIONS  SKIN RASH  ERLOTINIB EFFICACY  GEFITINIB  EGFR  TRIAL  BENEFIT  ADENOCARCINOMA  non-small cell lung cancer  icotinib  antitumor activity  adverse events